account_balance
Investment manager · 13F filer · SEC CIK 1596468
Almitas Capital LLC
Reported value$417Mas of Jun 30, 2026
Positions130 35 new, 20 sold out
Top 10 weight52.4%FBTC alone is 17%
FiledAug 1748 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
FBTCFidelity Wise Origin Bitcoin
16.7%Trimmed −11%
BTTBlackRock Mun Target Term Tr
8.1%
ASAAsa Gold and Precious MTLS L
7.8%Added +20%
AMLXAmylyx Pharmaceuticals Inc
4.2%Trimmed −54%
DSGNDesign Therapeutics Inc
3.6%Trimmed −33%
PDXPimco Dynamic Income Strateg
2.7%
CRFCornerstone Total Return Fd
2.7%Added +41%
CNNECannae Hldgs Inc
2.6%
MEGINyli Cbre GBL Infr Megtrnds
2.0%Added +76%
LYELLyell Immunopharma Inc
2.0%
BMEZBlackRock Health Sciences Te
1.9%
ANTX1.7%FBTCFidelity Wise Origin Bitcoin
16.7%Trimmed −11%
BTT8.1%ASAAsa Gold and Precious MTLS L
7.8%Added +20%
AMLX4.2%DSGN3.6%PDX2.7%CRF2.7%CNNE2.6%MEGI2.0%LYEL2.0%BMEZ1.9%ANTX1.7%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
FBTC Fidelity Wise Origin Bitcoin 16.7% Trimmed −11%BTT BlackRock Mun Target Term Tr 8.1% HeldASA Asa Gold and Precious MTLS L 7.8% Added +20%AMLX Amylyx Pharmaceuticals Inc 4.2% Trimmed −54%DSGN Design Therapeutics Inc 3.6% Trimmed −33%PDX Pimco Dynamic Income Strateg 2.7% HeldCRF Cornerstone Total Return Fd 2.7% Added +41%CNNE Cannae Hldgs Inc 2.6% HeldMEGI Nyli Cbre GBL Infr Megtrnds 2.0% Added +76%LYEL Lyell Immunopharma Inc 2.0% HeldBMEZ BlackRock Health Sciences Te 1.9% HeldANTX An2 Therapeutics Inc 1.7% Held
What changed